Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Neuroscience Letters

• Publication date

  1998-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0304-3940(98)00198-0PMID 9605478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine‐induced Fos expression in striatal neurons

  1998cited by this paper
• Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats.

  1997cited by this paper
• Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test.

  1997cited by this paper
• An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism.

  1997cited by this paper
• Basal ganglia and movement disorders: an update.

  1996cited by this paper
• Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study.

  1996cited by this paper
• Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats.

  1994cited by this paper
• Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase.

  1994cited by this paper
• Serotonergic sprouting in primate MTP-induced hemiparkinsonism

  1993cited by this paper
• Selective lesion of the nigrostriatal dopaminergic pathway by MPTP and acetaldehyde or diethyldithiocarbamate.

  1992cited by this paper
• Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain.

  1991cited by this paper
• Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats.

  1991cited by this paper
• Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: an anatomical, biochemical and pharmacological study.

  1989cited by this paper
• Sprouting of serotoninergic afferents into striatum after dopamine‐depleting lesions in infant rats: A retrograde transport and immunocytochemical study

  1986cited by this paper
• Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey.

  1984cited by this paper
• Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats.

  1984cited by this paper
• Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

  1983cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• L-Dopa: Effect on Concentrations of Dopamine, Norepinephrine, and Serotonin in Brains of Mice

  1970cited by this paper
• L-Dopa: Effect of Concentrations of Dopamine, Norepinephrine, and Serotonin in Brains of Mice

  1970cited by this paper
• Decrease of cerebral 5‐hydroxytryptamine by 3,4‐dihydroxyphenylalanine after inhibition of extracerebral decarboxylase

  1968cited by this paper

• A novel brainstem-targeted G51D α-synuclein fibril-injected mouse model exhibits sequential emergence of sleep and motor dysfunction.

  2026cites this paper
• Functional Neuroanatomy of the Normal and Pathological Basal Ganglia.

  2024cites this paper
• Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA

  2020cites this paper
• Serotonin in Parkinson's disease

  2020cites this paper
• Compensatory neuritogenesis of serotonergic afferents within the striatum of a transgenic rat model of Parkinson's disease.

  2020cites this paper
• Physical activity sustains memory retrieval in dopamine-depleted mice previously treated with L-Dopa.

  2019cites this paper
• Definition and Classification of Parkinsonian Drugs

  2019cites this paper
• MPTP Mouse Model of Preclinical and Clinical Parkinson’s Disease as an Instrument for Translational Medicine

  2018cites this paper
• Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys

  2018cites this paper
• Big Lessons from Tiny Flies: Drosophila melanogaster as a Model to Explore Dysfunction of Dopaminergic and Serotonergic Neurotransmitter Systems

  2018cites this paper
• PET Molecular Imaging in Familial Parkinson's Disease.

  2018cites this paper
• Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification.

  2017cites this paper
• Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease.

  2017cites this paper
• Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia : The Findings , the Debate , and the Therapeutic Implications

  2017cites this paper
• Les neurones à calrétinine du striatum : comparaisons inter-espèces et études anatomopathologiques

  2017cites this paper
• Pyrrolidine dithiocarbamate ameliorates rotenone-induced Parkinson’s disease in rats

  2017cites this paper
• Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs

  2017cites this paper
• Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.

  2017cites this paper
• Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys

  2016influential citation
• Dramatic differences in susceptibility to l-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion.

  2016cites this paper
• MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.

  2016cites this paper
• Antiparkinsonian Treatment for Depression in Parkinson's Disease: Are Selective Serotonin Reuptake Inhibitors Recommended?

  2016cites this paper
• Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.

  2016cites this paper
• Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia : The Findings , the Debate , and the Therapeutic Implications

  2016cites this paper
• Effects of prolonged neuronal nitric oxide synthase inhibition on the development and expression of L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats.

  2015cites this paper
• Putaminal serotonergic innervation

  2015influential citation
• Monoamine Reuptake Inhibitors in Parkinson's Disease

  2015cites this paper
• Functional Interplay between Dopaminergic and Serotonergic Neuronal Systems during Development and Adulthood.

  2015cites this paper
• Dorsal-to-Ventral Shift in Midbrain Dopaminergic Projections and Increased Thalamic/Raphe Serotonergic Function in Early Parkinson Disease

  2015cites this paper
• Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease

  2014cites this paper
• Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications

  2014cites this paper
• the findings, the debate, and the therapeutic implications

  2014cites this paper
• PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease.

  2014cites this paper
• On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis

  2014cites this paper
• Sistema serotonergikoaren eta gongoil basalen arteko elkarrekintza: inplikazio funtzionala eta terapiaren alderdia Parkinsonen gaixotasunean

  2014cites this paper
• Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease.

  2013cites this paper
• MALDI Mass Spectrometry Imaging of 1-Methyl-4-phenylpyridinium (MPP+) in Mouse Brain

  2013cites this paper
• Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios.

  2013cites this paper
• Serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice.

  2013cites this paper
• L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease.

  2012influential citation
• Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia.

  2012cites this paper
• Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease.

  2012cites this paper
• Contribution of Serotonergic Transmission to the Motor and Cognitive Effects of High-Frequency Stimulation of the Subthalamic Nucleus or Levodopa in Parkinson’s Disease

  2012cites this paper
• Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.

  2011cites this paper
• Age- and duration-dependent effects of MPTP on cortical serotonin systems.

  2011cites this paper
• The serotonergic system in Parkinson's disease.

  2011cites this paper
• Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease

  2011cites this paper
• Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation

  2011cites this paper
• thyl-eicosapentaenoate ( E-EPA ) attenuates motor impairments and nflammation in the MPTP-probenecid mouse model of Parkinson ’ s disease

  2011cites this paper
• Experimental modeling of preclinical and clinical stages of Parkinson’s disease

  2011cites this paper
• Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.

  2010cites this paper
• Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice.

  2010cites this paper
• Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia.

  2010cites this paper
• 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

  2010cites this paper
• Innervation dopaminergique et sérotoninergique du striatum dans les maladies de Parkinson et d'Huntington

  2010cites this paper
• Environmental Toxins and Dopaminergic Neurotoxicity: Novel Neuroprotective Strategies

  2009cites this paper
• The rat dyskinesia model: neurochemical and behavioural characterisation

  2009cites this paper
• Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation

  2009cites this paper
• Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone‐induced Parkinson's disease models

  2009cites this paper
• Long-term neurobiological consequences of ecstasy: a role for pre-existing trait-like differences in brain monoaminergic functioning?

  2009cites this paper
• The Corticostriatal Pathway in Parkinson’s Disease

  2009cites this paper
• Università degli Studi di Ferrara DOTTORATO DI RICERCA IN " Farmacologia e Oncologia Molecolare "

  2009cites this paper
• Università degli Studi di Ferrara DOTTORATO DI RICERCA IN FARMACOLOGIA ED ONCOLOGIA MOLECOLARE

  2009cites this paper
• Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.

  2009cites this paper
• Non-human Primate Models of Parkinson's Disease and Experimental Therapeutics

  2008cites this paper
• Degenerative and compensatory features in the striatum of MPTP-treated mice

  2008cites this paper
• Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity.

  2008cites this paper
• Interaction of the Dopaminergic and Serotonergic Systems in Rat Brain

  2008cites this paper
• Changes in the serotonergic system in the main olfactory bulb of rats unilaterally deprived from birth to adulthood

  2007cites this paper
• A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.

  2007cites this paper
• Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats.

  2007cites this paper
• Long-Term L-DOPA Treatment Causes Indiscriminate Increase in Dopamine Levels at the Cost of Serotonin Synthesis in Discrete Brain Regions of Rats

  2007cites this paper
• Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.

  2007cites this paper
• Modifications neurochimiques au sein des ganglions de la base et comportements moteurs associés lors d'une stimulation électrique du noyau subthalamique chez le rat hémiparkinsonien ou de la mise en place de la dénervation dopaminergique chez le singe

  2006influential citation
• Clozapine Modulates Aromatic l-Amino Acid Decarboxylase Activity in Mouse Striatum

  2006cites this paper
• Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice.

  2005cites this paper
• A role of IL-1 in MPTP-induced changes in striatal dopaminergic and serotoninergic transporter binding: clues from interleukin-1 type I receptor-deficient mice.

  2005cites this paper
• A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long‐term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?

  2005cites this paper
• Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA.

  2005cites this paper
• Attenuation of paraquat-induced motor behavior and neurochemical disturbances by L-valine in vivo.

  2004cites this paper
• Long-term consequences of ecstasy abuse: towards understanding the role of individual variation

  2004cites this paper
• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates.

  2004cites this paper
• Neuroplasticity in the MPTP‐Lesioned Mouse and Nonhuman Primate

  2003cites this paper
• Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice.

  2003cites this paper
• Amino Acids and Biogenic Amines in Cerebrospinal Fluid of Patients with Parkinson's Disease

  2003cites this paper
• Host brain regulation of dopaminergic grafts function: Role of the serotonergic and noradrenergic systems in amphetamine‐induced responses

  2003cites this paper
• Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models.

  2003cites this paper
• Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson’s disease induced by co-administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate

  2003cites this paper
• DARPP-32 mediates serotonergic neurotransmission in the forebrain

  2002cites this paper
• Behavioral phenotyping of the MPTP mouse model of Parkinson's disease.

  2001cites this paper
• Serotonergic Heterotypic Sprouting in the Unilaterally Dopamine-Depleted Mouse Neostriatum

  2001cites this paper
• Suszeptibilitätsunterschiede im MPTP-Mausmodell für Morbus Parkinson: Untersuchung genetischer Einflußfaktoren anhand von Stammvergleichen

  2001cites this paper
• Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum.

  2001cites this paper
• Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice.

  2001cites this paper
• Fenfluramine‐induced increase in preproenkephalin mRNA levels in the striatum: Interaction between the serotonergic, glutamatergic, and dopaminergic systems

  2000cites this paper
• Spontaneous long‐term compensatory dopaminergic sprouting in MPTP‐treated mice

  2000cites this paper
• NMSP binding to dopamine and serotonin receptors in MPTP‐induced parkinsonism: relation to dopa therapy

  1999cites this paper
• Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease.

  1999cites this paper